Skip to main content
Published locations for Axi-cel a promising second-line treatment option for older patients with relapsed or refractory LBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Axi-cel a promising second-line treatment option for older patients with relapsed or refractory LBCL
User login
Username
Password
Reset your password
/content/axi-cel-promising-second-line-treatment-option-older-patients-relapsed-or-refractory-lbcl
/hematology-oncology/article/262410/b-cell-lymphoma/axi-cel-promising-second-line-treatment-option
/b-cell-lymphoma-icymi/article/262410/b-cell-lymphoma/axi-cel-promising-second-line-treatment-option